Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
999.4 DKK | -0.32% |
|
+1.19% | +43.20% |
09:22am | NOVO NORDISK : UBS gives a Neutral rating | ZD |
06-27 | European Equities Close Mostly Lower Thursday; Bank of England Warns of 'Sharp Correction' Risk | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.20% | 638B | |
+55.95% | 819B | |
-6.98% | 351B | |
+19.08% | 329B | |
+9.05% | 298B | |
+17.10% | 242B | |
+2.62% | 225B | |
+13.21% | 217B | |
+8.91% | 168B | |
-3.44% | 158B |
- Stock Market
- Equities
- NOVO B Stock
- News Novo Nordisk A/S
- Novo Nordisk's Bleeding Disorder Therapy Shows Superior Bleeding Rate Reduction in Phase 3 Study